3 Top Biotech Stocks to Buy in August
Investing in biotechnology companies is something of a feast-or-famine proposition. Companies in the industry are heavily dependent on research that may look promising in the lab, but which take years of expensive testing to prove out prior to approval. Success with those tests could bring fortune for those who invested before the product got big, while failure could bring ruin.
With that in mind, we asked three Motley Fool contributors to weigh the risks vs. potential rewards and each pick a biotech stock worth your consideration for a potential purchase this August. They picked Ligand Pharmaceuticals (NASDAQ: LGND), IQVIA Holdings (NYSE: IQV), and Aimmune Therapeutics (NASDAQ: AIMT). Read on to find out why and to help yourself make a more informed decision on whether any of them deserves a spot in your portfolio.
Image source: Getty Images.
Source Fool.com
